Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: An international, randomised, open-label, phase 3 study

1. Dreyling, M.
2. Jurczak, W.
3. Jerkeman, M.
4. Silva, R.S.
5. Rusconi, C.
6. Trneny, M.
7. Offner, F.
8. Caballero, D.
9. Joao, C.
10. Witzens-Harig, M.
11. Hess, G.
12. Bence-Bruckler, I.
13. Cho, S.-G.
14. Bothos, J.
15. Goldberg, J.D.
16. Enny, C.
17. Traina, S.
18. Balasubramanian, S.
19. Bandyopadhyay, N.
20. Sun, S.
21. Vermeulen, J.
22. Rizo, A.
23. Rule, S.